Fisher & Paykel Healthcare confirms cyber incident with no expected material impact
Fisher & Paykel Healthcare Corporation Limited has confirmed a cyber incident involving unauthorised and unlawful access to two employee email accounts and a subset of company files. In a statement dated 22 October 2026, the company said it “immediately activated its response protocols” to contain the incident and investigate.
The company does not expect any material impact on its financials or operations. That is the key point for investors following the dual-listed stock (NZX: FPH, ASX: FPH), given its products are sold in over 120 countries.
The statement does not disclose the cause, the source of the activity, the date of the intrusion or the types of files involved.
When big ASX news breaks, our subscribers know first
Operations, supply and patient data unaffected
The company’s statement points to continuity across its core operations. Manufacturing and supply, the engine behind its revenue, were not affected according to the announcement.
Business continuity
The company confirmed the following:
- No impact to products, manufacturing operations or supply chain
- Ability to supply and support customers and patients continues uninterrupted
- No evidence of ransomware or malware
- Incident believed to be contained
Patient data
The company stated there is no evidence that the unlawful activity compromised its system that maintains patient data. The wording is limited to the absence of evidence, and the statement does not go further than that.
The table below summarises the company’s position and why each area matters to investors.
| Area | Company statement | Investor relevance |
|---|---|---|
| Products and manufacturing | **No impact** to products or manufacturing operations | Production underpins the company’s revenue base |
| Supply chain | **No impact**; ability to supply and support customers and patients continues uninterrupted | Delivery to customers and patients is maintained |
| Patient data system | **No evidence** the activity compromised the system that maintains patient data | Relates to the sensitivity of data held by a healthcare company |
| Financials | Does **not expect any material impact** on financials or operations | Management’s current view on earnings exposure |
Response and notification steps
Some of the files accessed contained personally identifiable information, and the company is in the process of notifying those affected. It has also notified relevant authorities, though the statement does not name them.
Why cyber disclosures matter to investors
Listed companies are expected to keep the market informed of events that could affect their value, a principle known as continuous disclosure. Healthcare companies also hold sensitive personal information, so data-privacy obligations draw attention when files are accessed.
Investors tend to watch for any effect on operations and financial results, which is why the company addressed both directly.
The company’s FY27 profit guidance, upgraded in August on strong hospital product demand and expanding gross margins, is the earnings baseline against which any cyber-related cost would be judged.
What to watch
Investors may look for any further company updates on the incident. The announcement does not state a timeline for these.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea.
Stay Ahead on Healthcare News Before the Market Moves
Join 20,000+ investors receiving FREE breaking ASX news within minutes of release, complete with in-depth analysis and the full announcement. Click the “Free Alerts” button at Big News Blast to get healthcare alerts in your inbox the moment news breaks, so you are never the last to know.